Skip to content

Clinical trials

Completed Phase 1/2 Sarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 1/2 Status: Completed Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20016
20021
20031
20062
20074
20081
20094
20105
20112
20121
20135
20142
20153
20168
20176
20186
20193
20203
20214
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed75

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center4
National Cancer Institute (NCI)4
Eli Lilly and Company3
Royal Marsden NHS Foundation Trust3
Fuda Cancer Hospital, Guangzhou2
Grupo Espanol de Investigacion en Sarcomas2
Hutchmed2
Radiation Therapy Oncology Group2
AGO Study Group1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma75
Breast Neoplasms13
Ovarian Neoplasms12
Melanoma11
Neoplasm Metastasis9
Neoplasms9
Rhabdomyosarcoma8
Colorectal Neoplasms7
Gastrointestinal Stromal Tumors7
Pancreatic Neoplasms7

Trials

Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.